🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05792267
Recruiting Not applicable

Clinical Research on a Novel Deep-learning Based System in Pancreatic Endoscopic Ultrasound Scanning

NCT05792267 · tracked via the Priya Life Science China tracker
Sponsor
The Third Xiangya Hospital of Central South University
Phase
Not applicable
Started
2021-01-01
Last updated
2025-02-12

Condition(s) studied

Pancreatic Disease

Investigational drug(s) / intervention(s)

artificial intelligence system

artificial intelligence system: Patients will undergo EUS examination with the assistance of artificial intelligence(AI) system.

Study summary

The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in pancreatic ultrasound endoscopic scanning.The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2. Whether the artificial intelligence system can improve the efficiency of the pancreatic scanning for the ultrasound endoscopist. Participants will undergo pancreatic EUS with or without the assistance of the artificial intelligence system.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 1\. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography of pancreas; 3. Agree to participate in this study and sign the informed consent form. Exclusion Criteria: * Subjects who meet any of the following criteria cannot be selected for this trial: First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography: 1. Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc. 2. Anesthesia assessment failed 3. Pregnancy or breastfeeding 4. In the acute stage of chemical and corrosive injury, it is very easy to cause perforation 5. Recent acute coronary syndrome or clinically unstable ischemic heart attack 6. Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure\> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome. Second. Disagree to participate in this study. Third. There are other problems that do not meet the requirements of this research or that affect the results of the research: 1. Pancreatic disease has undergone surgery or radiotherapy and chemotherapy beforehand; 2. Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Third Xiangya Hospital of Central South University Changsha Hunan Recruiting

More The Third Xiangya Hospital of Central South University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05792267 on ClinicalTrials.gov ↗ ← All trials in China